N.Y. Federal Bankruptcy Court Extends Stay of Litigation Against Purdue Pharma



DOCUMENTS
  • Order


NEW YORK — A New York federal bankruptcy court has extended a stay of litigation against OxyCotin maker Purdue Pharma L.P. through April 2020 pending the OxyCotin maker's Chapter 11 bankruptcy proceedings.

In a Nov. 6 order, Judge Robert D. Drain of the U.S. Bankruptcy Court for the Northern District of Ohio said that continuation of the active litigation “would result in irreparable harm to the debtors and their reorganization.”

Purdue filed a voluntary petition for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Southern District of New York on Sept. 15 following its agreement to settle thousands …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS